Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Project Updates and Milestones news
1 June 2026
Moderna & Merck: 5‑Year Data — Intismeran plus KEYTRUDA Reduces Recurrence in High‑Risk Resected Stage III/IV Melanoma
5-year Phase 2b follow-up: combination showed 49% RFS reduction (HR 0.51), 59% DMFS reduction (HR 0.411); OS trend (HR 0.471). Safety consistent; increased neoantigen-specific T‑cell clonotypes
1 June 2026
bp starts non-associated gas production at ACG
Commercial NAG started from West Chirag; well tests Qirmaki sands. Est. 4–6 Tcf recoverable; gas sent to Sangachal via existing infrastructure.
1 June 2026
Linde 2025 Sustainability Report
2025: 10% absolute GHG cut vs 2021; 50% electricity from low-carbon/renewables; customers avoided ~98M tCO2e; conserved 1B+ gallons water; diverted 200M lbs waste; supported ~2,100 orgs, 400k people.
1 June 2026
Vopak and Gasunie take conditional FID to extend EemsEnergyTerminal
Conditional FID approved for extension of EemsEnergyTerminal, advancing LNG infrastructure; final FID pending permits. Customer contracts secured for LNG supply 2028–2036.
1 June 2026
Roche to present obesity‑portfolio data at ADA 2026
Phase II data show enicepatide and petrelintide yield meaningful weight loss with good safety/tolerability. Both advance toward Phase III; a Phase II combo trial starts mid‑2026
1 June 2026
CATL opens world’s largest energy-storage testbed for real-world validation
10-ha, RMB3bn Xiamen facility offers open station-level validation across five labs: 35kV/100MVA grid sim, 1kV–500kV HV tests, 20MW combustion, -50–100°C climate chambers, EMC for 40-ft containers
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
31 May 2026
Lilly: Retevmo reduces recurrence/death risk by 83% as adjuvant in early‑stage RET‑fusion NSCLC
Phase 3 LIBRETTO-432 randomized 151 early-stage RET‑fusion NSCLC patients; at 24‑month follow‑up EFS rates 92% vs 61% (treatment vs placebo). Safety: elevated ALT/AST manageable with dose changes.
31 May 2026
Johnson & Johnson PROTEUS Phase 3: Perioperative ERLEADA reduces risk of metastasis or death by 20%
Perioperative apalutamide + ADT (6 months pre/post-surgery) raised pCR/MRD to 8.9% vs 1%, delayed need for further therapy >6 vs 3.5 years, met dual primary endpoints; safety profile as expected.
31 May 2026
Johnson & Johnson: RYBREVANT FASPRO shows durable responses in advanced head and neck cancer
Phase 1b/2 OrigAMI-4: subcutaneous amivantamab + hyaluronidase achieved 42% ORR (15% CR) in pretreated recurrent/metastatic HNSCC; median DOR not reached (11.8 mo FU); manageable safety.
29 May 2026
Velocys, Tetracore sign MOU to evaluate modular GTL in Nigeria
MOU to assess modular Fischer-Tropsch microFTL for Atakobo GTL in Ogun State - convert ~55 MMSCFD (~5,000 BPD) into diesel, Jet-A1 and naphtha to support domestic fuel supply.
29 May 2026
Johnson & Johnson: RYBREVANT + LAZCLUZE yields 41‑month median OS in first‑line atypical EGFR‑mutant NSCLC
CHRYSALIS-2 Phase1/1b (n=49): first-line atypical EGFR‑mutant NSCLC showed ORR 57%; 3‑yr OS 55%, 4‑yr OS 46%; 41% remained on treatment ≥2 years; safety consistent with prior reports.
29 May 2026
Petrobras to invest over R$70 billion in Sergipe
R$70B in Sergipe funds SEAP deep-water (P-81/P-87 FPSOs: 240k bpd, gas processing), 32 wells, 134 km pipeline; R$12.5B decommission 26 shallow platforms; fertilizer restarted (1.8k t/d)
29 May 2026
Rompetrol Rafinare Q1 2026: Turnover up 8%, net profit achieved
Q1: EBITDA $27.5M; March shutdown (700+ tasks) completed; Petromidia processed ~1.2Mt, white product yield 83.76%; domestic fuel share 66%; state contribution $577M
29 May 2026
Johnson & Johnson: TECVAYLI improves PFS and OS in second-line multiple myeloma
Phase 3 MajesTEC‑9: teclistamab cut progression/death risk 71% (HR 0.29) and death 40% (HR 0.60) vs PVd/Kd in early RRMM; higher ≥CR (65.9% vs 16.8%); infections and CRS increased
29 May 2026
EU Innovation Fund Net‑Zero Call: 358 applications, €17.5bn requested (6× budget)
Applicants across 27 countries submitted large/medium/small projects, pilots and cleantech manufacturing for energy‑intensive, carbon management, renewables and storage; results Oct 2026
29 May 2026
Merck: FDA Grants Breakthrough Designation to Calderasib (MK‑1084) for First‑Line KRAS G12C‑Mutant Metastatic NSCLC
Supports calderasib plus pembrolizumab in PD‑L1 ≥1% newly diagnosed metastatic KRAS G12C NSCLC; positive Phase 1 KANDLELIT‑001 data; multiple Phase 3 trials planned; developed with Taiho/Astex
29 May 2026
IFF to sell Food Ingredients business to CVC
Food Ingredients business sold for ~$4.3B (≈10x EBITDA); seller retains ~10% stake; net proceeds ~$3.8B for debt reduction, buybacks and reinvestment; close by end Q2 2027.
29 May 2026
AGC verifies AFLAS FFKM fluorine as 100% recycled under UL 2809
Mass-balance allocation applied to AFLAS FFKM; product offers strong chemical/heat/plasma resistance for semiconductor seals. Part of effort to recycle plant fluorine waste and advance circularity.
29 May 2026
Eni and Seri Industrial to develop LFP stationary battery supply chain
Agreement to build integrated LFP battery platform: cell/module plants, BESS assembly, recycling and cathode production. 2nd gigafactory >8 GWh by 2029; BESS line ready H1 2027. 30% stake for €55m.
28 May 2026
Johnson & Johnson: FDA approves TREMFYA label update for PsA joint‑damage inhibition
APEX Phase‑3b: in biologic‑naïve PsA patients, 24‑week results met ACR20 and significantly inhibited structural joint damage vs placebo; placebo switchers had 57% less radiographic progression to Week 48; safety unchanged.
28 May 2026
SkyNRG and KLM start construction of Netherlands' first dedicated SAF plant
Construction begins on DSL-01. First commercial-scale SAF plant to secure non‑recourse financing; aims for ~100,000 t/yr by 2028 via HEFA from low‑quality feedstocks, >100 jobs and €16M JTF support.
28 May 2026
PureCycle Achieves ISO 9001:2015 Certification
DQS-audited QMS at Ironton plant confirms repeatable, auditable production of near-virgin PureFive resin; adds to FDA NOLs, GreenCircle, APR, CosPaTox and REACH validations.
28 May 2026
Aptar Pharma files patents and reports preclinical proof‑of‑concept for intranasal and pulmonary GLP‑1 delivery
Published three international patent applications for nasal/pulmonary GLP‑1 formulations (spray‑dried/powder). Preclinical semaglutide PK shows up to 10× Cmax vs oral; ongoing biologics delivery work.
28 May 2026
GSK’s bepirovirsen: 19% functional cure in Phase III chronic hepatitis B trials
Pooled Phase III trials: 26% functional cure in patients with ≤1000 IU/mL HBsAg; 49% reached qHBsAg ≤100 IU/mL at 1 year; acceptable safety; regulatory reviews and anticipated Q3 2026 decisions.
28 May 2026
TotalEnergies Files Authorization for 1.5 GW Centre Manche Energies Offshore Wind
Operator submitted Single Authorization for Normandy offshore wind farm; expects ~6 TWh/yr, >1M homes, €4.5bn investment, 2,500 construction jobs, ongoing stakeholder consultations
28 May 2026
ORLEN Group Q1 2026: solid results and lowest fuel prices in the EU
Q1 results: LIFO EBITDA PLN14.1bn, revenue PLN75.8bn, net profit PLN8.1bn; operating cash flow PLN8.5bn; record PLN9.3bn dividend; PLN5.4bn capex on energy security and low-carbon projects
28 May 2026
Johnson Matthey preliminary results year ended 31 March 2026
Strategy driving cash: free cash flow £168m (+163%); pro forma underlying operating profit +6% at constant PGM/FX. Catalyst sale £1,325m on track; Cormetech buy agreed; new PGM refinery 2027.
28 May 2026
UPM and Sappi sign definitive agreement on graphic paper JV
Definitive deal to form 50/50 graphic paper JV combining two European businesses; €600m debt + €100m RCF secured; combined EV €1,420m; ~€100m annual synergies; regulatory approvals pending
28 May 2026
FDA approves Clariant's Licocare RBW for rigid PVC food‑contact use
FDA clears rice-bran wax additives for rigid PVC: all grades approved for direct food contact up to 0.5% and for food-processing equipment up to 1%; renewable, biodegradable; EFSA/Japan authorized.
28 May 2026
Lhyfe & STRABAG partner on green hydrogen in Germany
Co-development deal to accelerate green hydrogen projects in Germany amid RED III-driven RFNBO demand, combining electrolysis production, construction, financing and transport; possible EU expansion.
Next →
